Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Czeche, Sittah
Schüssel, Katrin
Franzmann, Alexandra
Burkart, Martin
and
Schulz, Martin
2013.
Dosage strength is associated with medication persistence with Ginkgo biloba drug products: a cohort study of ambulatory drug claims data in Germany.
BMC Complementary and Alternative Medicine,
Vol. 13,
Issue. 1,
Di Pierro, Francesco
2014.
Roles of Chemical Complexity and Evolutionary Theory in Some Hepatic and Intestinal Enzymatic Systems in Chemical Reproducibility and Clinical Efficiency of Herbal Derivatives.
The Scientific World Journal,
Vol. 2014,
Issue. ,
p.
1.
Eckert, Gunter P.
2015.
Ethnopharmacology.
p.
239.
Sarris, Jerome
Gerbarg, Patricia L.
Brown, Richard P.
and
Muskin, Philip R.
2015.
Psychiatry.
p.
2261.
Liu, Xu
Hao, Wenlin
Qin, Yiren
Decker, Yann
Wang, Xuan
Burkart, Martin
Schötz, Karl
Menger, Michael D.
Fassbender, Klaus
and
Liu, Yang
2015.
Long-term treatment with Ginkgo biloba extract EGb 761 improves symptoms and pathology in a transgenic mouse model of Alzheimer’s disease.
Brain, Behavior, and Immunity,
Vol. 46,
Issue. ,
p.
121.
Liu, Xin-Guang
Wu, Si-Qi
Li, Ping
and
Yang, Hua
2015.
Advancement in the chemical analysis and quality control of flavonoid in Ginkgo biloba.
Journal of Pharmaceutical and Biomedical Analysis,
Vol. 113,
Issue. ,
p.
212.
2015.
Phytopharmacy.
p.
168.
Fang, Xianying
Jiang, Yan
Ji, Hui
Zhao, Linguo
Xiao, Wei
Wang, Zhenzhong
and
Ding, Gang
2015.
The Synergistic Beneficial Effects of Ginkgo Flavonoid andCoriolus versicolorPolysaccharide for Memory Improvements in a Mouse Model of Dementia.
Evidence-Based Complementary and Alternative Medicine,
Vol. 2015,
Issue. ,
p.
1.
Wan, Wenbin
Zhang, Chunyan
Danielsen, Mark
Li, Qianlei
Chen, Wenjing
CHAN, Yuanjin
and
Li, Yaming
2016.
EGb761 improves cognitive function and regulates inflammatory responses in the APP/PS1 mouse.
Experimental Gerontology,
Vol. 81,
Issue. ,
p.
92.
Friel, Howard
and
Frautschy, Sally
2017.
A Paradigm Shift to Prevent and Treat Alzheimer's Disease.
p.
227.
Pan, Weidong
Zhu, Wei
Gao, Qi
Liao, Weilong
Gao, Penglin
Liu, Te
and
Rios, José L.
2018.
Effect of Yin‐Xing‐Tong‐Zhi Tablets on Improving Vascular Cognitive Impairment No Dementia.
Evidence-Based Complementary and Alternative Medicine,
Vol. 2018,
Issue. 1,
Pandey, Swapnil
Tiwari, Sudeep
Kumar, Anil
Niranjan, Abhishek
Chand, Jai
Lehri, Alok
and
Chauhan, Puneet Singh
2018.
Antioxidant and anti-aging potential of Juniper berry ( Juniperus communis L.) essential oil in Caenorhabditis elegans model system.
Industrial Crops and Products,
Vol. 120,
Issue. ,
p.
113.
Zeng, Gui-rong
Zhou, Shi-da
Shao, Ya-jie
Zhang, Miao-hong
Dong, Li-ming
Lv, Jing-wei
Zhang, Hong-xia
Tang, Ya-hui
Jiang, De-jian
and
Liu, Xin-min
2018.
Effect of Ginkgo biloba extract-761 on motor functions in permanent middle cerebral artery occlusion rats.
Phytomedicine,
Vol. 48,
Issue. ,
p.
94.
Wang, Jing
Chen, Xialin
Bai, Weirong
Wang, Zhenzhong
Xiao, Wei
and
Zhu, Jingbo
2021.
Study on Mechanism of Ginkgo biloba L. Leaves for the Treatment of Neurodegenerative Diseases Based on Network Pharmacology.
Neurochemical Research,
Vol. 46,
Issue. 7,
p.
1881.
García-Alberca, José María
Mendoza, Silvia
and
Gris, Esther
2022.
Benefits of Treatment with Ginkgo Biloba Extract EGb 761 Alone or Combined with Acetylcholinesterase Inhibitors in Vascular Dementia.
Clinical Drug Investigation,
Vol. 42,
Issue. 5,
p.
391.
García‐Alberca, José María
Gris, Esther
and
Mendoza, Silvia
2022.
Combined treatment with Ginkgo biloba extract EGb 761 plus acetylcholinesterase inhibitors improved cognitive function and neuropsychiatric symptoms in patients with mild cognitive impairment.
Alzheimer's & Dementia: Translational Research & Clinical Interventions,
Vol. 8,
Issue. 1,
Sarris, Jerome
Gerbarg, Patricia L.
Brown, Richard P.
and
Muskin, Philip R.
2023.
Tasman’s Psychiatry.
p.
1.
Guan, Yueyue
Tang, Guohua
Li, Lei
Shu, Jianzhong
Zhao, Yuhua
Huang, Li
and
Tang, Jun
2024.
Herbal medicine and gut microbiota: exploring untapped therapeutic potential in neurodegenerative disease management.
Archives of Pharmacal Research,
Vol. 47,
Issue. 2,
p.
146.